L0909 is an HCV inhibitor with an EC50 of 0.022 µM. L0909 blocks HCV replication by inhibiting E1-mediated viral entry. L0909 exhibits sensitivity to clinical resistant HCV mutants. L0909 displays synergistic effects with clinical HCV drugs. L0909 can be used for the research of hepatitis c virus (HCV) infection[1].
Molekulargewicht:
411.97
CAS Nummer:
[2085271-43-6]
Formel:
C23H30ClN5
Target-Kategorie:
HCV
Anwendungsbeschreibung:
MCE Product type: Reference compound1
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
